Overview: Gain valuable insights into South Korea’s in vitro diagnostics (IVD) market with Kalorama Information’s comprehensive report, The IVD Market in South Korea, 2024. We offer a detailed analysis of South Korea’s IVD revenues for 2023 and forecasts for 2028, segmented into key categories such as clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Our report also includes trends influencing the industry and country-level data, including disease incidence, life expectancy, population demographics, economic status, healthcare utilization, and other market influences. Length: 70 pages Published Date: February 2024 Key Segments Covered:
- Clinical Chemistry: Includes routine lab testing, urinalysis, blood chemistry testing, hematology, and hemoglobin tests.
- Immunoassays: Covers hormones, thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology, and common infectious diseases.
- Microbiology and Molecular Testing: Includes manual and automated tests, culture media, transport media, blood culture, sensitivity discs, and nucleic acid testing.
- Point-of-Care Testing: Encompasses POC tests for cardiology, toxicology, coagulation, diabetes, infectious diseases, blood gas, electrolytes, and glucose self-monitoring tests.
- Histology/Cytology: Covers PAP, HE, IHC, ISH, FISH, primary and secondary antibodies.
Scope: Our report is based on primary and secondary research conducted between January 2024 and February 2024. We interviewed industry participants, government officials, medical device regulators, distributors, healthcare providers, and global market participants. Secondary data sources included government databases, company literature, medical journals, and reports. All market data pertains to the South Korean IVD market at the manufacturers’ level, with data for 2023 and forecasts up to 2028 provided. Compound annual growth rates (CAGRs) are provided for the 2023-2028 period. Why Choose Our Report:
- Comprehensive Overview: Get a detailed analysis of South Korea’s IVD market and the factors shaping it.
- Industry Trends: Stay informed about the latest trends influencing the IVD market in South Korea.
- Strategic Insights: Use our data to make informed decisions and develop effective strategies for your business.
Don’t Miss Out: Stay ahead of the competition with our in-depth analysis of South Korea’s IVD market. Order now to receive valuable insights that can help drive your business forward. For further details and to purchase directly, please contact us. Sample Report: A sample is available as a PDF upon request. Table: South Korea In Vitro Diagnostic Sales, by Extracted Market Segment, 2023-2028 (in millions $)
| Segment | 2023 | 2028 | CAGR |
| General Chemistry | $XX Million | $XX Million | XX% |
| Blood Gas Analysis | $XX Million | $XX Million | XX% |
| Urinalysis | $XX Million | $XX Million | XX% |
| Hematology | $XX Million | $XX Million | XX% |
| Hemoglobin | $XX Million | $XX Million | XX% |
| Infectious Disease Immunoassays | $XX Million | $XX Million | XX% |
| Non-infectious Disease Immunos | $XX Million | $XX Million | XX% |
| Blood Bank Screening Immunoassays | $XX Million | $XX Million | XX% |
| POC Glucose | $XX Million | $XX Million | XX% |
| POC Infectious Disease | $XX Million | $XX Million | XX% |
| POC Other | $XX Million | $XX Million | XX% |
| ID/AST | $XX Million | $XX Million | XX% |
| Microbiology Molecular | $XX Million | $XX Million | XX% |
| Blood Screening NAT | $XX Million | $XX Million | XX% |
| HPV | $XX Million | $XX Million | XX% |
| CTC | $XX Million | $XX Million | XX% |
| Other Histology | $XX Million | $XX Million | XX% |
| Others | $XX Million | $XX Million | XX% |
| Total | $XX Million | $XX Million | XX% |
Source: Kalorama Information
